Director Cunningham Kenneth sold Verona Pharma plc ($VRNA) shares once on the open market in the last year, totaling $142,057. His most recent sale occurred on August 1, 2025. These sales rank 9,053rd among 11,678 individual insiders, where the average is $8.6 million across 6.37 transactions. He made no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Cunningham Kenneth | Director | D | Share Options (Right to Buy) | 64000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Cunningham Kenneth | Director | D | Ordinary Shares | 72000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Cunningham Kenneth | Director | M | Restricted Share Unit | 72000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Cunningham Kenneth | Director | D | Share Options (Right to Buy) | 200000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.03% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Cunningham Kenneth | Director | D | Share Options (Right to Buy) | 96000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Cunningham Kenneth | Director | D | Share Options (Right to Buy) | 240000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.03% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Cunningham Kenneth | Director | D | Ordinary Shares | 79776 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Cunningham Kenneth | Director | M | Ordinary Shares | 72000 | $0.00 | 72,000.0000 | 727,223,000 | 9999.99% | 0.01% |
| Aug. 1, 2025 | Verona Pharma plc | $VRNA | Cunningham Kenneth | Director | S | Ordinary Shares | 10808 | $13.14 | 79,776.0000 | 727,223,000 | 11.93% | 0.00% |
| Aug. 1, 2025 | Verona Pharma plc | $VRNA | Cunningham Kenneth | Director | M | Restricted Stock Units | 24000 | $0.00 | 72,000.0000 | 727,223,000 | 25.00% | 0.00% |
| Aug. 1, 2025 | Verona Pharma plc | $VRNA | Cunningham Kenneth | Director | M | Ordinary Shares | 24000 | $0.00 | 90,584.0000 | 727,223,000 | 36.04% | 0.00% |
| April 25, 2025 | Verona Pharma plc | $VRNA | Cunningham Kenneth | Director | A | Restricted Share Units | 96000 | $0.00 | 96,000.0000 | 652,311,000 | 9999.99% | 0.01% |
| April 29, 2024 | Verona Pharma plc | $VRNA | Cunningham Kenneth | Director | A | Share Options (Right to Buy) | 240000 | $0.00 | 240,000.0000 | 634,143,000 | 9999.99% | 0.04% |